These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7898731)

  • 1. Cisplatin neuropathy.
    Hol EM; Bär PR
    Neurology; 1995 Mar; 45(3 Pt 1):596; author reply 596-7. PubMed ID: 7898731
    [No Abstract]   [Full Text] [Related]  

  • 2. Protection of cisplatin-induced neuropathy: recent developments.
    Hamers F; Neijt J; Gispen W
    Pathol Biol (Paris); 1992 Nov; 39(9):829-30. PubMed ID: 1311436
    [No Abstract]   [Full Text] [Related]  

  • 3. Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-L-carnitine.
    Bianchi G; Vitali G; Caraceni A; Ravaglia S; Capri G; Cundari S; Zanna C; Gianni L
    Eur J Cancer; 2005 Aug; 41(12):1746-50. PubMed ID: 16039110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced glutathione protects against cisplatin-induced neurotoxicity in rats.
    Hamers FP; Brakkee JH; Cavalletti E; Tedeschi M; Marmonti L; Pezzoni G; Neijt JP; Gispen WH
    Cancer Res; 1993 Feb; 53(3):544-9. PubMed ID: 8425186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin-associated neurotoxicity: can it be prevented?
    Alberts DS; Noel JK
    Anticancer Drugs; 1995 Jun; 6(3):369-83. PubMed ID: 7670134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenesis mediates cisplatin-induced peripheral neuropathy: attenuation or reversal by local vascular endothelial growth factor gene therapy without augmenting tumor growth.
    Kirchmair R; Walter DH; Ii M; Rittig K; Tietz AB; Murayama T; Emanueli C; Silver M; Wecker A; Amant C; Schratzberger P; Yoon YS; Weber A; Panagiotou E; Rosen KM; Bahlmann FH; Adelman LS; Weinberg DH; Ropper AH; Isner JM; Losordo DW
    Circulation; 2005 May; 111(20):2662-70. PubMed ID: 15897348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin neuropathy.
    Cavaletti G; Tredici G
    Neurology; 1995 Mar; 45(3 Pt 1):596; author reply 596-7. PubMed ID: 7898730
    [No Abstract]   [Full Text] [Related]  

  • 8. [Selenium in the cytotoxicity of cisplatin].
    Olas B; Wachowicz B
    Postepy Hig Med Dosw; 1997; 51(1):95-108. PubMed ID: 9190574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Glutathione chemoprotection therapy against CDDP-induced neurotoxicity in patients with invasive bladder cancer].
    Sumiyoshi Y; Hashine K; Kasahara K; Karashima T
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1506-8. PubMed ID: 8854791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [About side effects of platinum drugs].
    Waszkiewicz K
    Postepy Hig Med Dosw; 2001; 55(3):387-406. PubMed ID: 11505639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological interventions to reduce platinum-induced toxicity.
    Tognella S
    Cancer Treat Rev; 1990 Sep; 17(2-3):139-42. PubMed ID: 2176930
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of 4-methylcatechol, a stimulator of endogenous nerve growth factor synthesis, on experimental acrylamide-induced neuropathy in rats.
    Saita K; Ohi T; Hanaoka Y; Furukawa S; Furukawa Y; Hayashi K; Matsukura S
    Neurotoxicology; 1995; 16(3):403-12. PubMed ID: 8584273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of herpes simplex virus-mediated neurotrophin gene transfer in cisplatin neuropathy.
    Chattopadhyay M; Goss J; Wolfe D; Goins WC; Huang S; Glorioso JC; Mata M; Fink DJ
    Brain; 2004 Apr; 127(Pt 4):929-39. PubMed ID: 14749293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of diabetes mellitus on the toxicity of therapy for advanced ovarian cancer.
    Gogas H; Shapiro F; Aghajanian C; Fennelly D; Almadrones L; Hoskins WJ; Spriggs DR
    Gynecol Oncol; 1996 Apr; 61(1):22-6. PubMed ID: 8626111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotrophic factors in the treatment of neurotoxicity: an overview.
    Apfel SC
    Neurotoxicology; 1996; 17(3-4):839-44. PubMed ID: 9086507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotoxic side-effects of cisplatin.
    Harmers FP; Gispen WH; Neijt JP
    Eur J Cancer; 1991; 27(3):372-6. PubMed ID: 1827334
    [No Abstract]   [Full Text] [Related]  

  • 17. A pilot study on the relation between cisplatin neuropathy and vitamin E.
    Bove L; Picardo M; Maresca V; Jandolo B; Pace A
    J Exp Clin Cancer Res; 2001 Jun; 20(2):277-80. PubMed ID: 11484987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuronopathy due to cisplatin].
    Cano JR; Catalán B; Jara C
    Rev Neurol; 1998 Oct; 27(158):606-10. PubMed ID: 9803507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. History of testicular cancer chemotherapy: maximizing efficacy, minimizing toxicity.
    Sweeney C
    Semin Urol Oncol; 2001 Aug; 19(3):170-9. PubMed ID: 11561984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal involvement in cisplatin neuropathy: prospective clinical and neurophysiological studies.
    Krarup-Hansen A; Helweg-Larsen S; Schmalbruch H; Rørth M; Krarup C
    Brain; 2007 Apr; 130(Pt 4):1076-88. PubMed ID: 17301082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.